ES2171646T3 - Uso de derivados de vinpocetina para la inhibicion o produccion de beta-proteina amiloide. - Google Patents

Uso de derivados de vinpocetina para la inhibicion o produccion de beta-proteina amiloide.

Info

Publication number
ES2171646T3
ES2171646T3 ES96901960T ES96901960T ES2171646T3 ES 2171646 T3 ES2171646 T3 ES 2171646T3 ES 96901960 T ES96901960 T ES 96901960T ES 96901960 T ES96901960 T ES 96901960T ES 2171646 T3 ES2171646 T3 ES 2171646T3
Authority
ES
Spain
Prior art keywords
sup
production
optionally replaced
vinpocetin
inhibition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES96901960T
Other languages
English (en)
Inventor
Mitsuru Kakihana
Takuo Kosaka
Akinobu Nagaoka
Giichi Goto
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Richter Gedeon Vegyeszeti Gyar Nyrt
Original Assignee
Richter Gedeon Vegyeszeti Gyar RT
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Richter Gedeon Vegyeszeti Gyar RT filed Critical Richter Gedeon Vegyeszeti Gyar RT
Application granted granted Critical
Publication of ES2171646T3 publication Critical patent/ES2171646T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/475—Quinolines; Isoquinolines having an indole ring, e.g. yohimbine, reserpine, strychnine, vinblastine

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

UN COMPOSICION FARMACEUTICA PARA INHIBIR LA PRODUCCION O SECRECION DE PROTEINA {BE} AMILOIDE, QUE INCLUYE UN COMPUESTO DE FORMULA (I), EN EL QUE EL ANILLO A ES UN ANILLO BENCENICO OPCIONALMENTE SUSTITUIDO, R REPRESENTA OR{SUP,1}, (A) O SR{SUP,1}, EN DONDE R{SUP,1}, R{SUP,2} Y R{SUP,3} SON IGUALES O DIFERENTES Y CADA UNO ESTA SELECCIONADO A PARTIR DE UN ATOMO DE HIDROGENO, UN GRUPO HIDROCARBURO OPCIONALMENTE SUSTITUIDO O R{SUP,2} Y R{SUP,3}, TOMADOS JUNTO CON EL ATOMO DE NITROGENO ADYACENTE, FORMAN UN GRUPO HETEROCICLICO QUE CONTIENE NITROGENO OPCIONALMENTE SUSTITUIDO, Y Y ES UN GRUPO ALQUILO OPCIONALMENTE SUSTITUIDO, O UNA SAL DEL MISMO FARMACEUTICAMENTE ACEPTABLE, SI NECESARIO, CON UN EXCIPIENTE, TRANSPORTADOR O DILUYENTE FARMACEUTICAMENTE ACEPTABLE.
ES96901960T 1995-02-15 1996-02-08 Uso de derivados de vinpocetina para la inhibicion o produccion de beta-proteina amiloide. Expired - Lifetime ES2171646T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2668795 1995-02-15

Publications (1)

Publication Number Publication Date
ES2171646T3 true ES2171646T3 (es) 2002-09-16

Family

ID=12200316

Family Applications (1)

Application Number Title Priority Date Filing Date
ES96901960T Expired - Lifetime ES2171646T3 (es) 1995-02-15 1996-02-08 Uso de derivados de vinpocetina para la inhibicion o produccion de beta-proteina amiloide.

Country Status (11)

Country Link
US (1) US5965568A (es)
EP (1) EP0813411B1 (es)
AT (1) ATE212227T1 (es)
AU (1) AU4632996A (es)
CA (1) CA2213094A1 (es)
DE (1) DE69618765T2 (es)
DK (1) DK0813411T3 (es)
ES (1) ES2171646T3 (es)
HU (1) HUP9801155A3 (es)
PT (1) PT813411E (es)
WO (1) WO1996025161A1 (es)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000024392A1 (fr) * 1998-10-26 2000-05-04 Sumitomo Pharmaceuticals Company, Limited Inhibiteur de la formation de beta-amyloide
US8153646B2 (en) * 2000-08-10 2012-04-10 Dart Neuroscience (Cayman) Ltd. Phosphodiesterase 4 inhibitors for cognitive and motor rehabilitation
ATE526020T1 (de) * 2000-08-10 2011-10-15 Cold Spring Harbor Lab Gesteigertes kognitives training
WO2004047854A2 (en) * 2002-11-22 2004-06-10 Novartis Ag Methods for the treatment of alzheimers disease and compositions therefore
EP1679059A4 (en) * 2003-10-28 2009-11-04 Univ Mexico Nacional Autonoma USE OF VINPOCETIN TO AVOID COMPLICATIONS, ESPECIALLY IN CONNECTION WITH THE ELEMENT WHICH APPEARS IN EPILEPSY, AND ITS TREATMENT
GB0329498D0 (en) 2003-12-19 2004-01-28 Novartis Ag Organic compounds
CZ2006628A3 (cs) * 2004-03-12 2007-01-24 Egis Gyogyszergyár Nyrt. Kombinovaná farmaceutická kompozice pro inhibici poklesu kognitivních funkcí
JP5160764B2 (ja) 2006-10-13 2013-03-13 全薬工業株式会社 特定の構造の複素環化合物を含む抗鬱剤、脳保護剤、アミロイドβ沈着抑制剤または老化抑制剤
KR101095026B1 (ko) * 2009-01-23 2011-12-20 한국과학기술연구원 비스(스티릴)피리미딘 및 비스(스티릴)벤젠 유도체, 이의 약학적으로 허용 가능한 염, 이의 제조방법 및 이를 유효성분으로 함유하는 베타아밀로이드 집적 관련 질환의 예방 또는 치료용 약학적 조성물
WO2010103539A2 (en) 2009-03-09 2010-09-16 Dinesh Shantilal Patel Sustained release oral formulation of vinpocetine
CN102875547B (zh) * 2011-07-15 2015-05-27 海南灵康制药有限公司 一种长春西汀化合物及其制法

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4035370A (en) * 1971-11-03 1977-07-12 Richter Gedeon Vegyeszeti Gyar Rt. Alkaloid esters
HU181941B (en) * 1979-11-23 1983-11-28 Richter Gedeon Vegyeszet Process for producing apovincaminic acid ester derivatives
HU201674B (en) * 1987-08-26 1990-12-28 Richter Gedeon Vegyeszet Process for producing pharmaceutical composition suitable for curing autoimmune-type leukoencephalomyelitic diseases e.g. sclerosis multiplex
JPH02167279A (ja) * 1988-09-30 1990-06-27 Taisho Pharmaceut Co Ltd アポビンカミン酸誘導体
JPH02152979A (ja) * 1988-12-06 1990-06-12 Taisho Pharmaceut Co Ltd アポビンカミン酸誘導体
JPH02204488A (ja) * 1989-02-03 1990-08-14 Taisho Pharmaceut Co Ltd エブルナメニン誘導体
JP3053913B2 (ja) * 1991-07-15 2000-06-19 帝三製薬株式会社 ビンポセチン類含有貼付剤
US5296478A (en) * 1992-10-07 1994-03-22 The Dupont Merck Pharmaceutical Co. 1-substituted oxindoles as cognition enhancers
EP0683234B2 (en) * 1993-01-25 2007-06-06 Takeda Chemical Industries, Ltd. Antibody against beta-amyloid or their derivative and use thereof

Also Published As

Publication number Publication date
ATE212227T1 (de) 2002-02-15
WO1996025161A1 (en) 1996-08-22
HUP9801155A3 (en) 1999-03-01
DK0813411T3 (da) 2002-05-13
DE69618765T2 (de) 2002-10-17
AU4632996A (en) 1996-09-04
HUP9801155A2 (hu) 1998-09-28
PT813411E (pt) 2002-07-31
EP0813411A1 (en) 1997-12-29
US5965568A (en) 1999-10-12
EP0813411B1 (en) 2002-01-23
CA2213094A1 (en) 1996-08-22
DE69618765D1 (de) 2002-03-14

Similar Documents

Publication Publication Date Title
ATE169031T1 (de) Zellrezeptor spezifische monoklonale antikörper gegen stammzell-faktor-rezeptor
ES2171646T3 (es) Uso de derivados de vinpocetina para la inhibicion o produccion de beta-proteina amiloide.
DK0644883T3 (da) Enniatiner og enniatinderivater til bekæmpelse af endoparasitter
MX9100628A (es) Compuestos peptidomimeticos de borolisina y procedimiento para su preparacion.
CL2003002756A1 (es) Compuestos derivados de (1-carbamoil-1,1-defenilmetil)-1-[substituido)alquil]purrolidinas; composicion farmaceutica que comprende a dicho compuesto; y uso del compuesto en el tratamiento del sindrome de intestino irritable o incontinencia.
DE69325130D1 (de) N-sulfonyl-2-oxoindol-derivate mit einer affinität für die vasopressin und/oder ocytocin rezeptoren
FI941457A0 (fi) Verihiutaleglyproteiini IIb/IIIa:n inhibiittoreina käyttökelpoisia syklisiä yhdisteitä
ES2132882T3 (es) Compuestos de 1-aril-2-acilamino-etano y su uso como antagonistas de neuroquinina 1.
ATE165357T1 (de) Neue verwendung bis-heterocyclische verbindungen und dessen zusammensetzungen
ECSP941050A (es) Derivados de benzofurano, proceso para su preparacion y composicion farmaceutica que los contiene
NO880851D0 (no) Fremgangsmaate for fremstilling av nye renin-inhibitorer.
DK0555351T3 (da) Oxysulfonylcarbamater
ES444625A1 (es) Procedimiento para preparar derivados de octapeptidos conte-niendo azufre.
ES2032838T3 (es) Un procedimiento para preparar derivados tetrahidropirido (1,2-a)indol.
AR119912A1 (es) Compuestos inhibidores de rip1
FI905992A0 (fi) Menetelmä metyleeni-pristinamysiini-IA- tai metyleeni-virginiamysiinijohdannaisten valmistamiseksi
MX9205469A (es) Heterociclos triciclicos
EA199800204A1 (ru) Антагонисты 5-нтрецепторов для лечения дискинезии
AR011169A1 (es) Compuestos derivados de quinoxalinadionas, su uso para la preparacion de medicamentos, compuestos intermediarios y procedimiento para preparar dichos medicamentos
CO5690639A2 (es) Compuestos de pirazol aciclico para la inhibicion de proteina cinasa-2 activada por proteina cinasa activada por mitogenos
MX20102A (es) Procedimiento para la preparacion de derivados de benzopirano.
AR009445A1 (es) Compuestos n-(piridinilamino)isoindolinas y compuestos relacionados, composiciones farmaceuticas, usos en la fabricacion de medicamentos para eltratamiento de la disfuncion de la memoria y la depresion, procedimiento de preparacion de dichos compuestos y compuestos intermediarios
NO930648D0 (no) Analogifremgangsmaate for fremstilling av angiogenese-hemmende oksaspiro(2.5)oktanderivater

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 813411

Country of ref document: ES